PLA2G7associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells-Reference-Cited by-同舟云学术

PLA2G7associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells

Published:2017-04 Issue:2 Volume:3 Page:123-138
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Path: Clin Res

Author:

Lehtinen Laura¹,Vainio Paula¹,Wikman Harriet²,Huhtala Heini³,Mueller Volkmar⁴,Kallioniemi Anne⁵,Pantel Klaus²,Kronqvist Pauliina¹,Kallioniemi Olli⁶,Carpèn Olli¹,Iljin Kristiina⁷

Affiliation:

1. Department of Pathology; Turku University and Turku University Hospital; Turku Finland

2. Institute of Tumour Biology, Centre of Experimental Medicine; University Medical Centre Hamburg-Eppendorf; Germany

3. School of Health Sciences; University of Tampere; Tampere Finland

4. Department of Gynecology; University Medical Center Hamburg-Eppendorf; Hamburg Germany

5. BioMediTech; University of Tampere; Tampere Finland

6. FIMM, Institute for Molecular Medicine Finland; University of Helsinki; Finland

7. VTT Technical Research Centre of Finland; Espoo Finland

Funder

Cancer Organizations of Finland

Sigrid Juselius Foundation

TIME collaborative project

Maud Kuistilan Muistosäätiö

K. Albin Johanssons Stiftelse

Research Foundation for Clinical Chemistry

the Academy of Finland

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference63 articles.

1. Global cancer statistics, 2012;Torre;CA: A Cancer Journal for Clinicians,2015

2. Molecular markers for breast cancer diagnosis, prognosis and targeted therapy;Lang;J Surg Oncol,2015

3. Management of triple negative breast cancer;Oakman;Breast (Edinburgh, Scotland),2010

4. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival;Woodward;Journal of Clinical Oncology,2003

5. Cancer metastasis: building a framework;Gupta;Cell,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La phospholipase A2 associée aux lipoprotéines (Lp-PLA2) : biomarqueur pertinent et cible thérapeutique ?;Annales Pharmaceutiques Françaises;2024-09

2. Bioinformatics Analysis Identifies PLA2G7 as a Key Antigen-Presenting Prognostic Related Gene Promoting Hepatocellular Carcinoma through the STAT1/PD-L1 Axis;Frontiers in Bioscience-Landmark;2024-01-23

3. Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma;Journal for ImmunoTherapy of Cancer;2024-01

4. Prostat Kanserinde Yağ Damlacık Oluşumu ile İlişkili PLA2G7, UCP2 ve NEDD4L Genlerinin Protein Ekspresyonlarının Araştırılması;Online Türk Sağlık Bilimleri Dergisi;2023-12-18

5. The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism;Nature Communications;2023-09-15